| Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease LF Burbulla, P Song, JR Mazzulli, E Zampese, YC Wong, S Jeon, ... Science 357 (6357), 1255-1261, 2017 | 730 | 2017 |
| Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy MA Passini, J Bu, AM Richards, C Kinnecom, SP Sardi, LM Stanek, Y Hua, ... Science translational medicine 3 (72), 72ra18-72ra18, 2011 | 565 | 2011 |
| iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis DC Schöndorf, M Aureli, FE McAllister, CJ Hindley, F Mayer, B Schmid, ... Nature communications 5 (1), 4028, 2014 | 536 | 2014 |
| Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain SP Sardi, J Murtie, S Koirala, BA Patten, G Corfas Cell 127 (1), 185-197, 2006 | 389 | 2006 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 382 | 2018 |
| ER stress and autophagic perturbations lead to elevated extracellular α-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons HJR Fernandes, EM Hartfield, HC Christian, E Emmanoulidou, Y Zheng, ... Stem cell reports 6 (3), 342-356, 2016 | 355 | 2016 |
| Acid β‐glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α‐synuclein processing V Cullen, SP Sardi, J Ng, YH Xu, Y Sun, JJ Tomlinson, P Kolodziej, I Kahn, ... Annals of neurology 69 (6), 940-953, 2011 | 355 | 2011 |
| CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy MA Passini, J Bu, EM Roskelley, AM Richards, SP Sardi, CR O’Riordan, ... The Journal of clinical investigation 120 (4), 1253-1264, 2010 | 346 | 2010 |
| Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders K Roy, JC Murtie, BF El-Khodor, N Edgar, SP Sardi, BM Hooks, ... Proceedings of the National Academy of Sciences 104 (19), 8131-8136, 2007 | 340 | 2007 |
| CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy SP Sardi, J Clarke, C Kinnecom, TJ Tamsett, L Li, LM Stanek, MA Passini, ... Proceedings of the National Academy of Sciences 108 (29), 12101-12106, 2011 | 339 | 2011 |
| Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies SP Sardi, J Clarke, C Viel, M Chan, TJ Tamsett, CM Treleaven, J Bu, ... Proceedings of the National Academy of Sciences 110 (9), 3537-3542, 2013 | 285 | 2013 |
| iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson’s disease CM Woodard, BA Campos, SH Kuo, MJ Nirenberg, MW Nestor, M Zimmer, ... Cell reports 9 (4), 1173-1182, 2014 | 257 | 2014 |
| Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases AJ Espay, JA Vizcarra, L Marsili, AE Lang, DK Simon, A Merola, ... Neurology 92 (7), 329-337, 2019 | 212 | 2019 |
| Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein EJ Bae, NY Yang, M Song, CS Lee, JS Lee, BC Jung, HJ Lee, S Kim, ... Nature communications 5 (1), 4755, 2014 | 200 | 2014 |
| Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations H Li, A Ham, TC Ma, SH Kuo, E Kanter, D Kim, HS Ko, Y Quan, SP Sardi, ... Autophagy 15 (1), 113-130, 2019 | 194 | 2019 |
| Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models SP Sardi, C Viel, J Clarke, CM Treleaven, AM Richards, H Park, ... Proceedings of the National Academy of Sciences 114 (10), 2699-2704, 2017 | 185 | 2017 |
| Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease LM Stanek, SP Sardi, B Mastis, AR Richards, CM Treleaven, T Taksir, ... Human gene therapy 25 (5), 461-474, 2014 | 183 | 2014 |
| Targeted therapies for Parkinson's disease: from genetics to the clinic SP Sardi, JM Cedarbaum, P Brundin Movement Disorders 33 (5), 684-696, 2018 | 169 | 2018 |
| Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort T Simuni, A Siderowf, S Lasch, CS Coffey, C Caspell‐Garcia, D Jennings, ... Movement Disorders 33 (5), 771-782, 2018 | 153 | 2018 |
| SMN regulates axonal local translation via miR-183/mTOR pathway MJ Kye, ED Niederst, MH Wertz, ICG Gonçalves, B Akten, KZ Dover, ... Human molecular genetics 23 (23), 6318-6331, 2014 | 146 | 2014 |
